A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 6, 2025

Primary Completion Date

March 23, 2026

Study Completion Date

April 23, 2026

Conditions
Narcolepsy Type 2
Interventions
DRUG

TAK-360

TAK-360 tablet.

OTHER

Placebo

TAK-360 matching placebo tablet.

Trial Locations (30)

133

NOT_YET_RECRUITING

Takeda Site 22, Rome

3080

NOT_YET_RECRUITING

Takeda Site 21, Seoul

16247

NOT_YET_RECRUITING

Takeda Site 19, Suwon

28037

ACTIVE_NOT_RECRUITING

Takeda Site 8, Denver

28046

NOT_YET_RECRUITING

Takeda Site 18, Madrid

34090

NOT_YET_RECRUITING

Takeda Site 17, Montpellier

40139

NOT_YET_RECRUITING

Takeda Site 23, Bellaria

75013

NOT_YET_RECRUITING

Takeda Site 15, Paris

100053

NOT_YET_RECRUITING

Takeda Site 28, Beijing

200040

NOT_YET_RECRUITING

Takeda Site 27, Shanghai

510515

NOT_YET_RECRUITING

Takeda Site 29, Guangzhou

999077

NOT_YET_RECRUITING

Takeda Site 25, New Territories

94063-3132

NOT_YET_RECRUITING

Takeda Site 14, Redwood City

92705-8519

NOT_YET_RECRUITING

Takeda Site 10, Santa Ana

80918-3408

NOT_YET_RECRUITING

Takeda Site 1, Colorado Springs

33511-5719

NOT_YET_RECRUITING

Takeda Site 13, Brandon

32803-1468

RECRUITING

Takeda Site 3, Orlando

63123-6968

RECRUITING

Takeda Site 4, St Louis

28078-5082

RECRUITING

Takeda Site 6, Huntersville

45245-4500

RECRUITING

Takeda Site 5, Cincinnati

29201-2923

RECRUITING

Takeda Site 2, Columbia

78229-4849

RECRUITING

Takeda Site 7, San Antonio

23510-1021

NOT_YET_RECRUITING

Takeda Site 11, Norfolk

222-0033

NOT_YET_RECRUITING

Takeda Site 24, Yokohama

862-0954

NOT_YET_RECRUITING

Takeda Site 9, Kumamoto

901-2132

NOT_YET_RECRUITING

Takeda Site 30, Urasoe

112-0012

NOT_YET_RECRUITING

Takeda Site 20, Bunkyo-ku

130-0004

NOT_YET_RECRUITING

Takeda Site 26, Sumida-Ku

532-0003

NOT_YET_RECRUITING

Takeda Site 12, Osaka

Unknown

NOT_YET_RECRUITING

Takeda Site 16, Junggu

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY

NCT06952699 - A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2) | Biotech Hunter | Biotech Hunter